<html>
<head>PUBMED IDs for USP34</head>
<body bgcolor='#C5F0F2'><h1>USP34</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23590831/'>Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34.</a> April 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24832791/'>Amplification of 2p as a genomic marker for transformation in lymphoma.</a> February 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24832776/'>End-stage renal disease in tuberous sclerosis complex-polycystic kidney disease contiguous gene syndrome: epidemiology, clinical manifestations and implications for transplantation.</a> May 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24911659/'>Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms.</a> July 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25900130/'>Characteristics of 2p15-p16.1 microdeletion syndrome: Review and description of two additional patients.</a> April 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25975428/'>An association study between USP34 and polycystic ovary syndrome.</a> March 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27699255/'>Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.</a> October 5  2016<br></body></html>
